Elbawab; Samer

Patent Applications and Registrations

Patent applications and USPTO patent grants for Elbawab; Samer.The latest application filed is for "arylpyrazinones such as but not limited to 3-(4-chlorophenyl-1-ethylpyrazin-2-(1h0)-one".

Company Profile

0.16.11

Elbawab; Samer - Bures-sur-Yvette FR
Elbawab; Samer - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of stimulating insulin secretion and/or modulating INS-1 kinase with substituted pyrazinones and/or substituted tetrahydroquinoxalinones Grant 9,233,937 - Botton , et al. January 12, 2	2016-01-12
Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 9,102,632 - Botton , et al. August 11, 2	2015-08-11
Tetrahydrotriazine compounds for treating diseases associated with AMPK activity Grant 9,035,048 - Cravo , et al. May 19, 2	2015-05-19
Arylpyrazinones Such As But Not Limited To 3-(4-chlorophenyl-1-ethylpyrazin-2-(1h0)-one App 20140329837 - BOTTON; Gerard ; et al.	2014-11-06
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,835,634 - unknownunknownBotton , et al. September 16, 2	2014-09-16
Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereof Grant 8,815,859 - Botton , et al. August 26, 2	2014-08-26
Pyrazinone Derivatives As Insulin Secreton Stimulators, Methods For Obtaining Them And Use Thereof For The Treatment Of Diabetes App 20140100235 - BOTTON; Gerard ; et al.	2014-04-10
Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,642,617 - Botton , et al. February 4, 2	2014-02-04
Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,637,522 - Botton , et al. January 28, 2	2014-01-28
Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,609,689 - Botton , et al. December 17, 2	2013-12-17
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes App 20130123257 - BOTTON; Gerard ; et al.	2013-05-16
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,415,352 - Botton , et al. April 9, 2	2013-04-09
Pyridopyrazinones Derivatives Insulin Secretion Stimulators, Methods For Obtaining Them And Use Thereof For The Treatment Of Diabetes App 20130023537 - BOTTON; Gerard ; et al.	2013-01-24
Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,178,556 - Botton , et al. May 15, 2	2012-05-15
Tetrahydrotriazine Compounds For Treating Diseases Associated With Ampk Acitivity App 20110236317 - Cravo; Daniel ; et al.	2011-09-29
Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes App 20110046159 - Botton; Gerard ; et al.	2011-02-24
Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes App 20110015210 - Botton; Gerard ; et al.	2011-01-20
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes App 20110015194 - Botton; Gerard ; et al.	2011-01-20
Pyridopyrazinones Derivatives Insulin Secretion Stimulators, Methods For Obtaining Them And Use Thereof For The Treatment Of Diabetes App 20110009417 - Botton; Gerard ; et al.	2011-01-13
Gm3 Synthase as a Therapeutic Target in Microvascular Complications of Diabetes App 20070224200 - Elbawab; Samer ; et al.	2007-09-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.